242 related articles for article (PubMed ID: 33579956)
21. Spinal Opioid Tolerance Depends upon Platelet-Derived Growth Factor Receptor-
Puig S; Barker KE; Szott SR; Kann PT; Morris JS; Gutstein HB
Mol Pharmacol; 2020 Oct; 98(4):487-496. PubMed ID: 32723769
[TBL] [Abstract][Full Text] [Related]
22. Novel fentanyl-based dual μ/δ-opioid agonists for the treatment of acute and chronic pain.
Podolsky AT; Sandweiss A; Hu J; Bilsky EJ; Cain JP; Kumirov VK; Lee YS; Hruby VJ; Vardanyan RS; Vanderah TW
Life Sci; 2013 Dec; 93(25-26):1010-6. PubMed ID: 24084045
[TBL] [Abstract][Full Text] [Related]
23. Loss of morphine reward and dependence in mice lacking G protein-coupled receptor kinase 5.
Glück L; Loktev A; Moulédous L; Mollereau C; Law PY; Schulz S
Biol Psychiatry; 2014 Nov; 76(10):767-74. PubMed ID: 24629717
[TBL] [Abstract][Full Text] [Related]
24. Molecular mechanisms of fentanyl mediated β-arrestin biased signaling.
de Waal PW; Shi J; You E; Wang X; Melcher K; Jiang Y; Xu HE; Dickson BM
PLoS Comput Biol; 2020 Apr; 16(4):e1007394. PubMed ID: 32275713
[TBL] [Abstract][Full Text] [Related]
25. Role of Efficacy as a Determinant of Locomotor Activation by Mu Opioid Receptor Ligands in Female and Male Mice.
Santos EJ; Banks ML; Negus SS
J Pharmacol Exp Ther; 2022 Jul; 382(1):44-53. PubMed ID: 35489781
[TBL] [Abstract][Full Text] [Related]
26. Predicting opioid receptor binding affinity of pharmacologically unclassified designer substances using molecular docking.
Ellis CR; Kruhlak NL; Kim MT; Hawkins EG; Stavitskaya L
PLoS One; 2018; 13(5):e0197734. PubMed ID: 29795628
[TBL] [Abstract][Full Text] [Related]
27. Molecular modeling of mu opioid receptor and receptor-ligand interaction.
Rong SB; Zhu YC; Jiang HL; Zhao SR; Wang QM; Chi ZQ; Chen KX; Ji RY
Zhongguo Yao Li Xue Bao; 1997 Jul; 18(4):317-22. PubMed ID: 10072913
[TBL] [Abstract][Full Text] [Related]
28. Opioid peptide receptor studies. 7. The methylfentanyl congener RTI-4614-4 and its four enantiomers bind to different domains of the rat mu opioid receptor.
Lu YF; Xu H; Liu-Chen LY; Chen C; Partilla JS; Brine GA; Carroll FI; Rice KC; Lai J; Porreca F; Sadee W; Rothman RB
Synapse; 1998 Feb; 28(2):117-24. PubMed ID: 9450512
[TBL] [Abstract][Full Text] [Related]
29. The absence of endogenous beta-endorphin selectively blocks phosphorylation and desensitization of mu opioid receptors following partial sciatic nerve ligation.
Petraschka M; Li S; Gilbert TL; Westenbroek RE; Bruchas MR; Schreiber S; Lowe J; Low MJ; Pintar JE; Chavkin C
Neuroscience; 2007 Jun; 146(4):1795-807. PubMed ID: 17467916
[TBL] [Abstract][Full Text] [Related]
30. Comparative neuropharmacology of structurally distinct non-fentanyl opioids that are appearing on recreational drug markets worldwide.
Vandeputte MM; Tsai MM; Chen L; Glatfelter GC; Walther D; Stove CP; Shi L; Baumann MH
Drug Alcohol Depend; 2023 Aug; 249():109939. PubMed ID: 37276825
[TBL] [Abstract][Full Text] [Related]
31. Ligand based conformational space studies of the μ-opioid receptor.
Sena DM; Cong X; Giorgetti A
Biochim Biophys Acta Gen Subj; 2021 Mar; 1865(3):129838. PubMed ID: 33373630
[TBL] [Abstract][Full Text] [Related]
32. Structure-based design of bitopic ligands for the µ-opioid receptor.
Faouzi A; Wang H; Zaidi SA; DiBerto JF; Che T; Qu Q; Robertson MJ; Madasu MK; El Daibani A; Varga BR; Zhang T; Ruiz C; Liu S; Xu J; Appourchaux K; Slocum ST; Eans SO; Cameron MD; Al-Hasani R; Pan YX; Roth BL; McLaughlin JP; Skiniotis G; Katritch V; Kobilka BK; Majumdar S
Nature; 2023 Jan; 613(7945):767-774. PubMed ID: 36450356
[TBL] [Abstract][Full Text] [Related]
33. Spinal or supraspinal phosphorylation deficiency at the MOR C-terminus does not affect morphine tolerance in vivo.
Kibaly C; Lin HY; Loh HH; Law PY
Pharmacol Res; 2017 May; 119():153-168. PubMed ID: 28179123
[TBL] [Abstract][Full Text] [Related]
34. Fentanyl but not Morphine Interacts with Nonopioid Recombinant Human Neurotransmitter Receptors and Transporters.
Torralva R; Eshleman AJ; Swanson TL; Schmachtenberg JL; Schutzer WE; Bloom SH; Wolfrum KM; Reed JF; Janowsky A
J Pharmacol Exp Ther; 2020 Sep; 374(3):376-391. PubMed ID: 32513839
[TBL] [Abstract][Full Text] [Related]
35. Opioid peptide receptor studies, 11: involvement of Tyr148, Trp318 and His319 of the rat mu-opioid receptor in binding of mu-selective ligands.
Xu H; Lu YF; Partilla JS; Zheng QX; Wang JB; Brine GA; Carroll FI; Rice KC; Chen KX; Chi ZQ; Rothman RB
Synapse; 1999 Apr; 32(1):23-8. PubMed ID: 10188634
[TBL] [Abstract][Full Text] [Related]
36. Ligand-Free Signaling of G-Protein-Coupled Receptors: Relevance to μ Opioid Receptors in Analgesia and Addiction.
Sadee W; McKew JC
Molecules; 2022 Sep; 27(18):. PubMed ID: 36144565
[TBL] [Abstract][Full Text] [Related]
37. Atomic-Level Characterization of the Methadone-Stabilized Active Conformation of
Kapoor A; Provasi D; Filizola M
Mol Pharmacol; 2020 Oct; 98(4):475-486. PubMed ID: 32680919
[TBL] [Abstract][Full Text] [Related]
38. Differences in tolerance to anti-hyperalgesic effects between chronic treatment with morphine and fentanyl under a state of pain.
Imai S; Narita M; Hashimoto S; Nakamura A; Miyoshi K; Nozaki H; Hareyama N; Takagi T; Suzuki M; Narita M; Suzuki T
Nihon Shinkei Seishin Yakurigaku Zasshi; 2006 Nov; 26(5-6):183-92. PubMed ID: 17240843
[TBL] [Abstract][Full Text] [Related]
39. Molecular recognition of morphine and fentanyl by the human μ-opioid receptor.
Zhuang Y; Wang Y; He B; He X; Zhou XE; Guo S; Rao Q; Yang J; Liu J; Zhou Q; Wang X; Liu M; Liu W; Jiang X; Yang D; Jiang H; Shen J; Melcher K; Chen H; Jiang Y; Cheng X; Wang MW; Xie X; Xu HE
Cell; 2022 Nov; 185(23):4361-4375.e19. PubMed ID: 36368306
[TBL] [Abstract][Full Text] [Related]
40. Structure-Based Design and Development of Chemical Probes Targeting Putative MOR-CCR5 Heterodimers to Inhibit Opioid Exacerbated HIV-1 Infectivity.
Huang B; Wang H; Zheng Y; Li M; Kang G; Barreto-de-Souza V; Nassehi N; Knapp PE; Selley DE; Hauser KF; Zhang Y
J Med Chem; 2021 Jun; 64(11):7702-7723. PubMed ID: 34027668
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
